Three words appear on every vial we ship and on every page of this site. Research use only. They are easy to read past, and they are the most consequential words in the whole catalog. RUO is not a disclaimer bolted on for comfort. It is a category that defines what a compound is, who may buy it, what a vendor is permitted to say about it, and what the buyer takes responsibility for. This article explains the category in plain terms.
What the category actually is
In the United States, drugs are regulated by the Food and Drug Administration. A drug is, in the regulatory sense, an article intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease, or intended to affect the structure or function of the body. Intent is the operative word. A molecule is not a drug because of its chemistry. It becomes one because of the purpose it is offered for.
A research use only product is offered for a different purpose: laboratory investigation. It is a reagent, sold to be measured, characterized, dissolved, assayed and written up. It has not been evaluated for safety or effectiveness in people, it carries no approved labeling, and it is not a drug. The RUO statement is how that intent is declared and kept unambiguous.
What RUO permits
Under the RUO framing a vendor can describe chemistry and published science. That means the amino acid sequence, the molecular weight, the solubility, the storage conditions, the analytical results for the lot, and an accurate summary of what the peer-reviewed literature reports about the compound in cell and animal models. A page about retatrutide can describe which receptors it engages. A page about BPC-157 can describe the rodent models it appears in. A page about NAD+ can describe its role as a coenzyme in redox reactions.
What RUO does not permit
The line is crossed the moment a claim points at a person. Statements that a compound heals an injury, reduces weight, improves sleep, restores energy or slows aging convert a reagent into an unapproved drug in the regulatory sense, no matter what the vial label says. So do instructions for administration, suggested amounts, schedules, protocols aimed at an individual, before-and-after photographs, and testimonials. A vendor cannot use the RUO label as a shield while marketing the product for personal use. The label describes intent, and marketing copy is evidence of intent.
What a compliant listing looks like
- Sequence, molecular formula, molecular weight and CAS number where one exists.
- Mass per vial, appearance, and the diluents the compound is compatible with.
- Storage and stability conditions for the lyophilized powder and for solution.
- Lot-specific HPLC purity and mass-spectrometry identity, with the certificate available.
- Literature described as literature: which model, which species, which endpoint.
- No amounts, no schedules, no routes described as instructions, no outcome promises.
- The research use only statement stated plainly rather than buried in small print.
Our checklist for evaluating a peptide vendor treats the absence of these items as a signal in itself. A catalog that talks in outcomes rather than chemistry is telling you how it thinks about the category.
The buyer's side of the arrangement
RUO is a two-sided declaration. The vendor states what is being sold. The purchaser states what it is for. Buying an RUO compound is an assertion that the material will be used in laboratory research by someone qualified to handle it, under whatever institutional oversight applies to that setting. Institutional review, biosafety approval, controlled-substance rules where relevant, import and export rules, waste handling and local law all remain the purchaser's responsibility. The vendor does not confer any authorization by shipping the vial.
This is also why RUO material should never be assumed suitable for clinical or diagnostic work. Diagnostic use has its own regulatory pathway with its own validation requirements, and a reagent released against a research specification has not been through it.
RUO and GMP supply are different supply chains
| Dimension | Research use only | Pharmaceutical (GMP) supply |
|---|---|---|
| Governing standard | Analytical specification set by the supplier | Good manufacturing practice guidelines for active ingredients and finished products |
| Release testing | Identity and purity, plus whatever else the supplier specifies | A validated, audited panel fixed in the filed specification |
| Documentation | Certificate of analysis per lot | Full batch record, validation history, change control, audit trail |
| Facility oversight | Supplier and its contract laboratories | Regulatory inspection of the manufacturing site |
| Intended recipient | A laboratory | A patient, through a licensed channel |
| Approved labeling | None | Required |
The distinction is about the system around the molecule, not the molecule itself. A compound can be chemically excellent and still be RUO, because RUO describes the documentation and oversight regime it was released under.
Why a certificate still matters under RUO
It would be easy to read the absence of pharmaceutical oversight as an absence of standards. That is the wrong conclusion. Without regulatory inspection in the background, analytical evidence is the only thing standing between a research result and an artifact of a bad reagent. If the vial contains a truncated sequence, the experiment measures the truncated sequence. If the powder is 70% counter-ion by mass, every concentration in the notebook is wrong.
That is why every Homegrown Peptides lot, across the peptide catalog, is tested by an independent laboratory for HPLC purity and mass-spectrometry identity before release, with the certificate available on request. Our guide to reading a certificate of analysis covers each line, and the tests a purity figure cannot see covers endotoxin, sterility and elemental contamination. Under RUO, that paperwork is the quality system.
Frequently asked questions
Does research use only mean the compound is unregulated?
No. It means it is not being offered as a drug. Other rules still apply, including controlled-substance law where relevant, import and export controls, shipping regulations and institutional requirements. RUO narrows the intended use rather than removing oversight.
Can an RUO compound be the same molecule as an approved drug?
Yes, and many are. The chemistry can be identical while the supply chain, documentation and intended use are entirely different. The reagent grade is not a substitute for the pharmaceutical article, and it is not supplied as one.
Why will a vendor not answer questions about personal use?
Because answering would change the intended use of the product and put the vendor outside the category it sells in. A supplier can discuss chemistry, handling, analytics and published literature. Anything beyond that belongs to a licensed professional, not a reagent supplier. Nothing on this site is legal advice.
References
- U.S. Food and Drug Administration, 2013, Guidance for Industry and FDA Staff, Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only.
- International Council for Harmonisation, 2000, ICH Q7, Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
- Mant, Chen and Hodges, 2007, Nature Protocols, HPLC analysis and purification of peptides.
- D'Hondt and colleagues, 2014, Journal of Pharmaceutical and Biomedical Analysis, Related impurities in peptide medicines.
Research use only. Everything in this article describes laboratory and preclinical research. Homegrown Peptides products are not for human or animal use, are not drugs, and are not intended to diagnose, treat, cure or prevent any disease. Nothing here is medical or legal advice.
